Australia - inglese - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 250 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; lactose; stearic acid; gelatin; titanium dioxide; sodium starch glycollate; tartaric acid; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 100 mg - capsule, hard - excipient ingredients: tartaric acid; sodium lauryl sulfate; iron oxide red; lactose; colloidal anhydrous silica; stearic acid; gelatin; sodium starch glycollate; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 20 mg - capsule, hard - excipient ingredients: tartaric acid; colloidal anhydrous silica; iron oxide yellow; gelatin; lactose; sodium lauryl sulfate; stearic acid; titanium dioxide; sodium starch glycollate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 5 mg - capsule, hard - excipient ingredients: indigo carmine; sodium lauryl sulfate; tartaric acid; iron oxide yellow; lactose; colloidal anhydrous silica; sodium starch glycollate; gelatin; stearic acid; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - interferon alfa-2b 5 miu/ml;   - solution for injection - 5 miu/ml - active: interferon alfa-2b 5 miu/ml   excipient: albumin dibasic sodium phosphate glycine methyl hydroxybenzoate monobasic sodium phosphate monohydrate propyl hydroxybenzoate water for injection

Nuova Zelanda - inglese - Ministry for Primary Industries

schering-plough animal health limited - tetanus antitoxin; clostridium perfringens type d toxoid - tetanus antitoxin 0 vaccine; clostridium perfringens type d toxoid 0 vaccine - vaccine

Nuova Zelanda - inglese - Ministry for Primary Industries

schering-plough animal health limited - dichelobacter nodosus - dichelobacter nodosus 0 vaccine - vaccine

Nuova Zelanda - inglese - Ministry for Primary Industries

schering-plough animal health limited - chlorhexidine digluconate (free base); glycerol - chlorhexidine digluconate (free base) 22.5 g/litre; glycerol 630 g/litre - antimicrobial

Nuova Zelanda - inglese - Ministry for Primary Industries

schering-plough animal health limited - clostridium perfringens type d toxoid; levamisole phosphate; clostridium septicum toxoid; clostridium tetani toxoid; clostridium chauvoei toxoid/cells; clostridium novyi type b toxoid/cells - clostridium perfringens type d toxoid 0 vaccine; levamisole phosphate 100 g/litre; clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine - endoparasiticide

Nuova Zelanda - inglese - Ministry for Primary Industries

schering-plough animal health limited - leptospira interrogans serovar hardjoprajitno; leptospira interrogans serovar icterohaemorrhagiae; leptospira interrogans serovar pomona - leptospira interrogans serovar hardjoprajitno 0 vaccine; leptospira interrogans serovar icterohaemorrhagiae 0 vaccine; leptospira interrogans serovar pomona 0 vaccine - vaccine